卡铂增强淋巴细胞与内皮细胞相互作用促进CD8+ T细胞转运至卵巢肿瘤微环境
本研究利用卵巢癌小鼠模型,探讨卡铂对淋巴细胞向肿瘤部位转运的影响。卡铂显著改变肿瘤微环境,促进淋巴细胞与肿瘤血管的黏附相互作用并改善淋巴细胞转运,效果优于抗PD-1或抗VEGFR-2治疗,可能有助于提高总生存期。
要点
- 卡铂可深刻改变卵巢癌肿瘤微环境,促进淋巴细胞与肿瘤血管的黏附互动。
- 卡铂在肿瘤微环境中的效果优于抗PD-1或抗VEGFR-2治疗。
- 卡铂可能通过改善淋巴细胞转运延长总生存期。
核心结论
- 卡铂通过增强淋巴细胞与内皮细胞相互作用促进CD8+ T细胞转运至卵巢肿瘤微环境,效果优于抗PD-1或抗VEGFR-2治疗,可能延长总生存期。
研究设计与样本
- 研究利用卵巢癌小鼠模型,比较卡铂、抗PD-1抗体或抗VEGFR-2抗体的淋巴细胞转运情况,采用活体显微镜测量黏附互动、免疫组化评估淋巴细胞归巢,并随访总生存期。
主要发现
- 卡铂深刻改变肿瘤微环境,促进淋巴细胞与肿瘤血管的黏附相互作用,改善淋巴细胞转运。
- 卡铂在肿瘤微环境中的测量结果优于抗PD-1治疗或抗VEGFR-2治疗,可能有助于提高卡铂治疗组的总生存期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Standard chemotherapy agents, including carboplatin, have known immunogenic properties. We sought to determine how carboplatin may influence lymphocyte trafficking to tumor sites. METHODS: Murine models of ovarian cancer were utilized to examine lymphocyte trafficking with common clinically used agents including carboplatin, anti-PD-1 antibody, or anti-VEGFR-2 antibody. Adhesion interactions of lymphocytes with tumor vasculature were measured using intravital microscopy, lymphocyte homing with immunohistochemistry, and treatment groups followed for overall survival. RESULTS: Carboplatin chemotherapy profoundly alters the tumor microenvironment to promote lymphocyte adhesive interactions with tumor vasculature and resultant improvement in lymphocyte trafficking. The measured results seen with carboplatin in the tumor microenvironment were superior to anti-PD-1 treatment or anti-VEGFR-2 which may have contributed to increased overall survival in carboplatin treated groups. CONCLUSIONS: These novel findings suggest a role for chemotherapeutic agents to broadly influence anti-tumor immune responses beyond the induction of immunogenic tumor cell death.
引用
- Mark J, Fisher DT, Kim M, et al. Carboplatin enhances lymphocyte-endothelial interactions to promote CD8+ T cell trafficking into the ovarian tumor microenvironment. Gynecol Oncol. 2022. PMID: 36410228. doi:10.1016/j.ygyno.2022.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。